IP Verse

Modified Bordetella Pertussis Strains - EP2802646

The patent EP2802646 was granted to Bionet Asia on May 10, 2017. The application was originally filed on Dec 20, 2012 under application number EP12871942A. The patent is currently recorded with a legal status of "Revoked".

EP2802646

BIONET ASIA
Application Number
EP12871942A
Filing Date
Dec 20, 2012
Status
Revoked
Feb 14, 2020
Grant Date
May 10, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GLAXO SMITHKLINE BIOLOGICALSFeb 9, 2018EVANSADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONEP0396964
OPPOSITIONUS5439810
OPPOSITIONWO0122993
OPPOSITIONWO2010135742
OPPOSITIONWO9534323
SEARCHEP0396964
SEARCHWO0122993
SEARCHWO9534323

Non-Patent Literature (NPL) Citations (23) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
INTERNATIONAL-SEARCH-REPORT- BARRY, E.M. ET AL., "Expression and immunogenicity of pertussis toxin S1 subunittetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.", INFECT. IMMUN., (1996), vol. 64, no. 10, pages 4172 - 4181, XP055157449
INTERNATIONAL-SEARCH-REPORT- LOOSMORE, S.M. ET AL., "Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.", INFECT. IMMUN., (1990), vol. 58, no. 11, pages 3653 - 3662, XP002910752
INTERNATIONAL-SEARCH-REPORT- SATO, Y. ET AL., "Development of acellular pertussis vaccines.", BIOLOGICALS, (1999), vol. 27, no. 2, pages 61 - 69, XP055157447
INTERNATIONAL-SEARCH-REPORT- PIZZA, M. ET AL., "Mutants of pertussis toxin suitable for vaccine development.", SCIENCE, (1989), vol. 246, no. 4929, pages 497 - 500, XP001016264
INTERNATIONAL-SEARCH-REPORT- INATSUKA, C.S. ET AL., "Pertactin is required for Bordetella species to resist neutrophil-mediated clearance.", INFECT. IMMUN., (2010), vol. 78, no. 7, pages 2901 - 2909, XP055157452
INTERNATIONAL-SEARCH-REPORT- BUASRI, W. ET AL., "Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange.", BMC MICROBIOL., (201204), vol. 12, no. 61, pages 1 - 16, XP021124669
OPPOSITION- BARRY, E.M. et al., "Expression and immunogenicity of pertussis toxin S1 subunittetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908", INFECT. IMMUN., (19960000), vol. 64, no. 10, pages 4172 - 4181, XP055157449
OPPOSITION- BUBOLTZ AM et al., "Role of the Type III Secretion System in a Hypervirulent Lineage of Bordetella bronchiseptica", Infection and Immunity, (20090900), vol. 77, no. 9, pages 3969 - 3977, XP055464301
OPPOSITION- CARL-HEINZ WIRSING VON KONIG, "Use of Antibiotics in the Prevention and Treatment of Pertussis", The Pediatric Infectious Disease Journal, (20050500), vol. 24, no. 5, pages S66 - S68, XP05546429
OPPOSITION- European Medicines Agency, "Note for Guidance on the quality, preclinical and clinical aspects of gene transfer medicinal products", EMEA Note CPMB/BWP/3088/99, (20010424), pages 1 - 32, XP055464307
OPPOSITION- LOOSMORE, S.M. et al., "Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine", INFECT. IMMUN., (19900000), vol. 58, no. 11, pages 3653 - 3662, XP002910752
OPPOSITION- Mark S. Peppler, Merry E. Schrumpf, "Isolation and Characterization of Bordetella pertussis Phenotype Variants Capable of Growing on Nutrient Agar: Comparison with Phases III and IV", Infection and Immunity, (19840100), vol. 43, no. 1, pages 217 - 223, XP055464298
OPPOSITION- ZEALEY, GR et al., "Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, (19920100), vol. 58, no. 1, pages 208 - 214, XP001025668
OPPOSITION- SATO, Y. et al., "Development of acellular pertussis vaccines", BIOLOGICALS, (19990000), vol. 27, no. 2, pages 61 - 69, XP055157447
OPPOSITION- LOOSMORE, SM et al., "Hybrid genes over-express pertactin from Bordetella pertussis", Vaccine, (19950400), vol. 13, no. 6, pages 571 - 560, XP000946603
OPPOSITION- PARKHILL J et al., "COMPARATIVE ANALYSIS OF THE GENOME SEQUENCES OF BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS AND BORDETELLA BRONCHISEPTICA", NATURE GENETICS, (20030901), vol. 35, no. 1, pages 32 - 40, XP008044372
OPPOSITION- PIZZA, M. et al., "Mutants of pertussis toxin suitable for vaccine development", SCIENCE, (19890000), vol. 246, no. 4929, pages 497 - 500, XP001016264
OPPOSITION- INATSUKA, C.S. et al., "Pertactin is required for Bordetella species to resist neutrophil-mediated clearance", INFECT. IMMUN., (20100000), vol. 78, no. 7, pages 2901 - 2909, XP055157452
OPPOSITION- "INFECTION AND IMMUNITY 2010 INSTRUCTIONS TO AUTHORS", INFECTION AND IMMUNITY, (20100101), vol. 78, no. 1, pages 1 - 20, XP055464286
OPPOSITION- BUASRI, W. et al., "Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange", BMC MICROBIOL., (20120400), vol. 12, no. 61, pages 1 - 16, XP021124669
OPPOSITION- LIU ZHANG et al., "Effect of Vaccination on Bordetella pertussis Strains, China", EMERGING INFECTIOUS DISEASES, (20101101), vol. 16, no. 11, pages 1695 - 1701, XP055200205
SEARCH- PARKHILL J ET AL, "COMPARATIVE ANALYSIS OF THE GENOME SEQUENCES OF BORDETELLA PERTUSSIS, BORDETELLA PARAPERTUSSIS AND BORDETELLA BRONCHISEPTICA", NATURE GENETICS, NATURE PUBLISHING GROUP, NEW YORK, US, (20030901), vol. 35, no. 1, doi:10.1038/NG1227, ISSN 1061-4036, pages 32 - 40, XP008044372 [Y] 1-15 * the whole document *
SEARCH- LIU ZHANG ET AL, "Effect of Vaccination on Bordetella pertussis Strains, China", EMERGING INFECTIOUS DISEASES, (20101101), vol. 16, no. 11, doi:10.3201/eid1611.100401, ISSN 1080-6040, pages 1695 - 1701, XP055200205 [Y] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents